Anthropic pays $400M for biotech; Praxis epilepsy drug hits in Phase 1/2 trialnews2026-04-06T14:37:53+00:00April 6th, 2026|Endpoints News|
Takeda ends partnership with Denali amid restructuringnews2026-04-06T14:19:14+00:00April 6th, 2026|Endpoints News|
Neurocrine will pay $2.9B for Soleno and its Prader-Willi medicinenews2026-04-06T11:32:55+00:00April 6th, 2026|Endpoints News|
Stipple Bio launches with $100M to find more precise targets on cancer proteinsnews2026-04-06T11:00:13+00:00April 6th, 2026|Endpoints News|
China’s Syneron raises $150M for peptides, adding to last year’s $100Mnews2026-04-06T10:50:19+00:00April 6th, 2026|Endpoints News|
Pharma’s dealmaking tear; Blackstone raises record fund; Xolair energizes allergy research; and more news2026-04-04T10:00:47+00:00April 4th, 2026|Endpoints News|
OpenLoop Health has acquired nutrition startup Season Healthnews2026-04-02T20:27:52+00:00April 2nd, 2026|Endpoints News|
Trump signs order to put 100% pharma tariffs on drugs, countries without trade dealsnews2026-04-02T19:59:29+00:00April 2nd, 2026|Endpoints News|
Aspect Biosystems gets $79M from Canadian government for diabetes cell therapynews2026-04-02T18:32:29+00:00April 2nd, 2026|Endpoints News|
DOJ weighs in favor of pharma on 340B disputenews2026-04-02T17:49:02+00:00April 2nd, 2026|Endpoints News|
